Genetics & Genomics Archive
-
September 12, 2023
Study finds new genetic susceptibilities for colon cancer
Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer. -
August 31, 2023
New reference tool supports replication of DNA biobank studies
Vanderbilt researchers created a phenotype-genotype reference map to assess data quality in DNA biobanks. -
July 20, 2023
Predicting gene expression may speed discovery: study
Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood. -
July 18, 2023
The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck
Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery. -
July 18, 2023
Alliance for Genomic Discovery FAQs
Here are frequently asked questions about Vanderbilt University Medical Center's Alliance for Genomic Discovery. -
July 17, 2023
Alzheimer’s genetic risk tracked across sex, race
A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race. -
July 14, 2023
Study uses statistical and population-based methods to understand comorbidities of developmental language disorder
A recent Vanderbilt study is one of the first to use statistical and population-based methods to understand comorbidities associated with developmental language disorder at a population level.